Her2+ Breast Cancer Detection
For effective use in detecting specific types of cancer, tumor-targeting nanoparticles must evade the immune system and remain intact for a clinically relevant…
Notice: Undefined index: file in /nas/content/live/imagionbx/wp-includes/media.php on line 1676
New Nanoparticle Technologies Arise from MD Anderson Collaboration
Rebeca Romero Aburto PhD is an Imagion Biosystems research collaborator and a post-doctoral fellow at the University of Texas MD Anderson Cancer Center. As an…
Say Hello to Imagion Biosystems
News! The nanotechnology-based cancer diagnostics-development company known as Senior Scientific is now Imagion Biosystems. The company has spun out from its…